Showing results (5641-5650 of 27,720) with videos related to
Sort By:
Pageof 2,772
Vaccine|June 19, 2012
Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adultsScott A Halperin, Shelly McNeil, Joanne M Langley, et al.Vaccine|June 19, 2012
Immunization with the conjugate vaccine Vi-CRM₁₉₇ against Salmonella typhi induces Vi-specific mucosal and systemic immune responses in miceFabio Fiorino, Annalisa Ciabattini, Simona Rondini, et al.Vaccine|July 11, 2012
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adultsBirgit Thierry-Carstensen, Karina Jordan, Hilde Hylland Uhlving, et al.Vaccine|July 4, 2012
Therapeutic vaccination with Salmonella-delivered codon-optimized outer inflammatory protein DNA vaccine enhances protection in Helicobacter pylori infected miceJiansen Chen, Miaoduan Lin, Neng Li, et al.Vaccine|July 4, 2012
A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infantsA A Odutola, O A Owolabi, P K Owiafe, et al.Vaccine|July 4, 2012
Modifying the thermostability of inactivated influenza vaccinesAlex Bliu, Michele Lemieux, Changgui Li, et al.Vaccine|July 4, 2012
Use of the 13-valent conjugate vaccine has the potential to eliminate pilus carrying isolates as causes of invasive pneumococcal diseaseSandra I Aguiar, José Melo-Cristino, Mário RamirezVaccine|July 4, 2012
Evaluation of a new serological technique for detecting rabies virus antibodies following vaccinationXiaoyue Ma, Michael Niezgoda, Jesse D Blanton, et al.Vaccine|July 4, 2012
Reduction of HPV infections through vaccination among at-risk urban adolescentsTeresa Cummings, Gregory D Zimet, Darron Brown, et al.Vaccine|April 1, 2015
The immunoglobulin M-degrading enzyme of Streptococcus suis, IdeSsuis, is a highly protective antigen against serotype 2Jana Seele, Lena-Maria Hillermann, Andreas Beineke, et al.Pageof 2,772